Smart insulin pump may protect diabetics during surgery
NCT ID NCT06947031
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at whether the Minimed 780G, an automated insulin pump system, helps people with type 1 diabetes keep their blood sugar in a safe range during surgery. Researchers analyzed data from 15 patients who used the system before, during, and after their operation. The goal was to see if the pump reduces dangerous low blood sugar episodes in the operating room.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Minimed 780G advanced hybrid closed loop system (insulin pump with continuous glucose monitor)
What this could lead to
If successful, this could show that automated insulin delivery systems help keep blood sugar stable during surgery, reducing risks for people with type 1 diabetes.
What could go wrong
This is a very small study (15 people) that only looks at data already collected. It cannot prove the system works better than other methods, and results may not apply to all patients or surgeries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitario San Ignacio
Bogota, Cundinamarca, 860.015.536-1, Colombia